Login / Signup

Study of efficacy and longevity of immune response to 3 rd and 4 th doses of COVID-19 vaccines in patients with cancer: a single arm clinical trial.

Astha ThakkarKith PradhanBenjamin DuvaJuan Manuel CarrenoSrabani SahuVictor ThiruthuvanathanSean CampbellSonia GallegoTushar D BhagatJohanna RiveraGaurav S ChoudharyRaul OleaMaite SabalzaLauren C ShapiroMatthew LeeRyann QuinnIoannis MantzarisEdward ChuBritta WillLiise-Anne PirofskiFlorian KrammerAmit K VermaBalazs Halmos
Published in: eLife (2023)
Clinical trial identifier: NCT05016622.
Keyphrases
  • clinical trial
  • immune response
  • coronavirus disease
  • sars cov
  • phase ii
  • study protocol
  • open label
  • double blind
  • dendritic cells
  • phase iii
  • randomized controlled trial
  • drosophila melanogaster